The Avlon plant near Bristol, which produced Astrazeneca’s blockbuster Crestor statin, called in administrators in FebruaryAnnual accounts for the drugs company behind several failed Big Pharma manufacturing sites are more than two months late, raising the threat of it being struck off the company register. Avara Pharmaceutical Services, owned by Leonard Levie, an American banker-turned-industrial investor, was required to file its 2018 accounts by the end of September. Avara, a contract manufacturer, struck deals with multinational companies including Astrazeneca and Glaxosmithkline. However, four of its sites, about half the portfolio, have failed or been taken back. They include the…

Source: The Times December 09, 2019 00:00 UTC